ACR Convergence 2024

November 14-19, 2024. Washington, DC.

View by Number View by Title View Sessions

All • a b c d e f g h i [j] k l m n o p q r s t u v w x y z

Abstract Number: 1117

JAK Inhibitor Therapy in Refractory Uveitis Due to Immune-mediated Inflammatory Disorders. Multicenter Study and Literature Review
Abstract Number: 0504

Janus Kinase Inhibitors Persist Longer Than Biologics in Rheumatoid Arthritis: Retrospective Analysis of Real-world Outpatient Data from the German Rhadar Database
Abstract Number: 0831

JDM Proteomic Signature at Disease Onset and Progression Highlights Persistent Dysregulation of Cell Death, Redox and Innate Immune Signaling
Abstract Number: 0380

Joint Acoustic Emissions as a Digital Biomarker for Knee Inflammation in Juvenile Idiopathic Arthritis: A Pilot Study Using Musculoskeletal Ultrasound as Ground Truth
Abstract Number: 0287

Joint Involvement in Cystic Fibrosis: Description of Clinical Phenotypes
Abstract Number: 1761

Juvenile Idiopathic Arthritis Genetic Risk Haplotypes: Relevance to Children of African Ancestry

All • a b c d e f g h i [j] k l m n o p q r s t u v w x y z